Skip to main content
Fig. 4 | Experimental Hematology & Oncology

Fig. 4

From: Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation

Fig. 4

NKG2D-dependent activation and GzmB production of NK cells and T lymphocytes. NK cells or T lymphocytes were pretreated with an anti-NKG2D antibody or a control IgG antibody for 30 min and then stimulated with exosomes for 6 h and 36 h, respectively. a–c The intracellular expression of GzmB in NK cells (a), CD4+ T cells (b) and CD8+ T cells (c) was measured by intracellular staining and flow cytometric analysis. Representative flow cytometry plots showing the expression level of intracellular GzmB in these immune cells. Values are presented as the means ± SD. *p < 0.05, **p < 0.01 vs. the corresponding ctrl IgG group

Back to article page